AVE5026: A novel, extractive heparinoid with enriched anti-Xa activity and enhanced Antithrombotic activity.

被引：1
|
作者：
Hoppensteadt, Debra [1 ]
Cunanan, Josephine [1 ]
Geniaux, Eric [2 ]
Lorenz, Martin [2 ]
Viskov, Christian [2 ]
Ythier-Moury, Pascal [2 ]
Brin, Jean-Francois [2 ]
Jeske, Walter [3 ]
机构：
[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[2] Sanofi Aventis, Paris, France
[3] Loyola Univ, Med Ctr, Cardiovasc Inst, Maywood, IL USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.1881.1881
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1881
引用
收藏
页码：557A / 557A
页数：1
相关论文
共 15 条
  • [1] AVE5026: a new hemisynthetic ultra low molecular weight heparin with enriched anti-Xa activity and enhanced antithrombotic activity for management of cancer associated thrombosis
    Gray, A.
    Hoppensteadt, D.
    Jeske, W.
    Walenga, J. M.
    Fareed, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 790 - 790
  • [2] AVE5026: A new hemisynthetic ultra low molecular weight heparin (ULMWH) with enriched anti-Xa activity and enhanced antithrombotic activity for management of cancer associated thrombosis
    Hoppensteadt, D.
    Jeske, W.
    Walenga, J.
    Fareed, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Anticoagulant and Antithrombotic Actions of AVE5026, an Enriched Anti-Xa Hemisynthetic Ultra-Low-Molecular-Weight Heparin
    Hoppensteadt, Debra A.
    Gray, Angel
    Jeske, Walter P.
    Walenga, Jeanine M.
    Fareed, Jawed
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (06) : 621 - 628
  • [4] Comparison of apixaban and rivaroxaban trough anti-Xa activity.
    Bookstaver, David
    Sparks, Kimberly
    Pybus, Brandon
    Davis, Dustin
    PHARMACOTHERAPY, 2016, 36 (12): : E239 - E239
  • [5] A new assay for point of care monitoring of heparin and heparinoid anti-Xa activity
    Hansen, R
    Koster, A
    Mertzlufft, F
    ANESTHESIA AND ANALGESIA, 1999, 88 (04): : U9 - U9
  • [6] Development and evaluation of PEGylated Enoxaparin: A novel approach for enhanced anti-Xa activity
    Choubey, Anupam Kumar
    Dora, Chander Parkash
    Bhatt, Tara Dutt
    Gill, Manjinder Singh
    Suresh, Sarasija
    BIOORGANIC CHEMISTRY, 2014, 54 : 1 - 6
  • [7] THE LACK OF RELATIONSHIP BETWEEN ANTI-XA ACTIVITY AND ANTITHROMBOTIC ACTIVITY OF LOW-MOLECULAR WEIGHT HEPARIN
    OCKELFORD, PA
    CARTER, CJ
    HIRSH, J
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 116 - 116
  • [8] DISCORDANCE BETWEEN THE ANTI-XA ACTIVITY AND THE ANTITHROMBOTIC ACTIVITY OF AN ULTRALOW MOLECULAR-WEIGHT HEPARIN FRACTION
    OCKELFORD, PA
    CARTER, CJ
    MITCHELL, L
    HIRSH, J
    THROMBOSIS RESEARCH, 1982, 28 (03) : 401 - 409
  • [9] EFFECTS OF A SERIES OF NOVEL SYNTHETIC PENTASACCHARIDES IN EXPERIMENTAL THROMBOSIS MODELS - CORRELATION OF ANTITHROMBOTIC EFFECT AND ANTI-XA ACTIVITY
    HOBBELEN, PMJ
    VANDINTHER, TG
    VOGEL, GMT
    MOELKER, HCT
    VANBOECKEL, CAA
    MEULEMAN, DG
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 534 - 534
  • [10] ARE MOLECULAR-WEIGHT AND ANTI-XA ACTIVITY SUFFICIENT TO PREDICT THE ANTITHROMBOTIC POWER OF HEPARIN FRACTIONS
    DOUTREMEPUICH, C
    BOUSQUET, F
    TOULEMONDE, F
    THROMBOSIS RESEARCH, 1986, 44 (05) : 709 - 712
12